In an executive order last week, President Donald Trump effectively instituted price controls on prescription drugs—not just those purchased by the government through Medicare and Medicaid ...

Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections. Sold under such brand names as Azo and Uristat, it’s available in most US ...

"So, yes, a large portion of patients starting GLP-1 drugs are already dealing with mental health struggles. But that’s not because of the drug — that’s because of the disease." Once these ...

U.S. President Donald Trump has launched a new effort to lower prescription drug prices for Americans that targets foreign nations — both for the lower prices they pay and the potential to ...

Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney ...

President Donald Trump used the story of an overweight friend getting weight-loss medication at a much lower cost overseas to illustrate why he’s working to cut prescription drug prices for ...

And I am hopeful for the first time in a long time. People are now commenting on my weight loss, and I have given credit to these new drugs. But the response has been … weird and unexpected.

This baby boy was treated with the first personalized gene-editing drug Doctors say they constructed a bespoke gene-editing treatment in less than seven months and used it to treat a baby with a ...

LEWISBURG — A registered nurse at WellSpan Evangelical Community Hospital in Lewisburg took fentanyl and midazolam home for personal use and replaced the medication with saline over four months ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics ...

After telehealth startups recently lost the ability to sell exact copies of patented GLP-1 weight-loss drugs, some firms have begun turning to a different, less effective medication that has been ...

Lakdawalla is the chief scientific officer at the USC Schaeffer Center for Health Policy & Economics. Goldman is the founding director of the USC Schaeffer Institute for Public Policy and ...